Barinthus Biotherapeutics (BRNS) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to -$75.6 million.
- Barinthus Biotherapeutics' Enterprise Value rose 2865.63% to -$75.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.6 million, marking a year-over-year increase of 2865.63%. This contributed to the annual value of -$112.3 million for FY2024, which is 2085.23% up from last year.
- Latest data reveals that Barinthus Biotherapeutics reported Enterprise Value of -$75.6 million as of Q3 2025, which was up 2865.63% from -$87.7 million recorded in Q2 2025.
- Over the past 5 years, Barinthus Biotherapeutics' Enterprise Value peaked at -$75.6 million during Q3 2025, and registered a low of -$243.1 million during Q2 2021.
- In the last 5 years, Barinthus Biotherapeutics' Enterprise Value had a median value of -$160.1 million in 2023 and averaged -$159.3 million.
- In the last 5 years, Barinthus Biotherapeutics' Enterprise Value tumbled by 39823.21% in 2021 and then surged by 3383.36% in 2024.
- Over the past 5 years, Barinthus Biotherapeutics' Enterprise Value (Quarter) stood at -$213.6 million in 2021, then increased by 9.15% to -$194.1 million in 2022, then increased by 26.9% to -$141.9 million in 2023, then grew by 20.85% to -$112.3 million in 2024, then surged by 32.7% to -$75.6 million in 2025.
- Its last three reported values are -$75.6 million in Q3 2025, -$87.7 million for Q2 2025, and -$100.5 million during Q1 2025.